On the 13th October we hosted a #kidneycancer patient day in Sheffield with the Uro-Oncology team at Weston Park Hospital. Thank you to the patients and speakers who joined us on the day, their contribution ensured the day was excellent. Find out more https://t.co/kAWyMi7Tk9

We would like to say a massive thank you to Joanna and Mikaela who completed on the 12th October the Bournemouth Supernova 5K run to raise funds for us. Thank you also to everyone who contributed to their fund raising. #kidneycancer #bypatientsforpatients #StrongerTogether

Earlier this week we hosted a #kidneycancer patient day in Truro with the help and support of the staff from Royal Cornwall Trust. We had speakers on a range of related topics and patients shared their experience of living with kidney cancer. Read more: https://t.co/kAWyMi8r9H

#Stoptober, started today. People across the country are taking steps to stop smoking. Stopping isn't easy - but there is free NHS support, advice and tools that can make your journey easier. To find out more and get support: https://t.co/g6gLR4baj8 #Stoptober

As members of the Coalition for Reducing Bureaucracy in Clinical Trials, we have been working hard to reduce bureaucracy in clinical trials, both for clinical researchers & patients, focussing on: informed consent, safety reporting & regulatory guidelines. https://t.co/WkmvoMxlcg

We've been working hard with the National Institute for Health and Care Excellence, to create guide lines which aim to reduce variation in treatment between hospitals and prevent unnecessary surgery for the removal of kidney tumours. About the guideline: https://t.co/vLaNY0UrWn

Stoptober starts in one weeks time, to get the support you need to quit for good. Find out more: https://t.co/Gwlzu0lDa7

Preparing for the 2nd Patient Advisory Board for the CARE1 Pragmatic Clinical Trial this afternoon, proud that #IKCC and Action Kidney Cancer are taking a lead role in providing the patient and public involvement for this important clinical trial #kidneycancer

💡 NKCA Clinical Fellow Dr. Raghav Varma will present hot off the press findings from the recent State of the Nation Report at the British Uro-oncology Group @BUG_UK25 Annual Meeting. 🗓️ Sept 13 @ 09.15 🔗  https://t.co/Cxa5HpELN0 @HQIP @NATCAN_news @kidneycanceruk @ACTION4KC

The 2025 NKCA reveals that only 1% of kidney cancer patients in England joined clinical trials from 2020 to 2022. We are raising awareness to help more #kidneycancer patients access innovative treatments through trial participation. Read more here: https://t.co/CbulhqcZrf

A recent study compares real world data on the outcomes of advanced #kidneycancer patients treated with an immunotherapy combination as a first-line treatment followed by a second-line TKI. To read more: https://t.co/9f1t8y9pQA

Benmelstobart a new immunotherapy, which blocks the action of the immunosuppressant, PD-L1, in combination with a TKI called anlotinib was compared with sunitinib as first-line treatment for advanced #kidneycancer Read More: https://t.co/1daOFOYGPh

Terrific Talk by Laurence Albiges (@AlbigesL) on Biomarkers in Kidney Cancer at IUCS25 - Sumanta K. Pal (@montypal) https://t.co/P4IgUGMT0a #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #IUCS25 #KidneyCancer @CancerWorldmag

We are delighted that our trustee Samra Turajlic is New Director of the Cancer Research UK Manchester Institute. @IKCCorg @CRUK_MI #kidneycancer

Researchers from the University of California in Los Angeles have developed a new kind of immunotherapy that uses specially engineered immune cells that attack #kidneycancer tumours without the need to customise treatment for each individual patient. https://t.co/q3jmzVnv7G

Julia one of our team was delighted to meet and thank three generations of the the Pointon family, Dave, Steve and Ernie, along with Clive Read & Jonnie Briggs from Crewe soul club and venue manager Phil Taylor who made the event a resounding success and raised a fantastic £2056.

T is for ... Treatment, we have a section on our website where you will find information about available #kidneycancer treatments. The section includes surgical options, medicines, clinical trials and much more. https://t.co/rLLDUWMytY #StrongerTogether

We are supporting the One Cancer Voice NHS Cancer Plan campaign which was presented in parliament. #OneCancerVoice #kidneycancer #StrongerTogether

C is for.. Clinical trials, if you would like to find out more about #kidneycancer trials, see where they are being held in the UK and read real patients experiences of being on one, we have a section on our website that provides this information. https://t.co/krCiqtjtKD

Fumarate hydratase-deficient rcc is a rare and aggressive type of #kidneycancer Because of this treatment is not clear. This phase two study shows treatment with a combination of immunotherapy and tyrosine kinase inhibitor, showed promise in patients. https://t.co/4QW7egqdsN